Results
1 -
5 of
5
(Click
here to explore results)
- Neglected sulfur(vi) pharmacophores in drug discovery: exploration of novel chemical space by the interplay of drug design and method development. U. Lücking
, Org. Chem. Front.
, 2019
, 6
, 1319
- CDK9 inhibitors in cancer research. Zhi Huang, Tianqi Wang, Cheng Wang, Yan Fan
, RSC Med. Chem.
, 2022
, 13
, 688
- One-pot synthesis of α-sulfoximinophosphonate via Kabachnik–Fields reaction. K. Natarajan, Suraj Sharma, C. P. Irfana Jesin, Ramesh Kataria, Ganesh Chandra Nandi
, Org. Biomol. Chem.
, 2022
, 20
, 7036
- Novel tacrine derivatives as potential CDK9 inhibitors with low cholinesterase inhibitory properties: design, synthesis, and biological evaluation. Wenwu Liu, Yaoguang Huang, Limeng Wu, Wenjie Liu, Xiaowen Jiang, Zihua Xu, Qingchun Zhao
, New J. Chem.
, 2022
, 46
, 19342
- Electrochemical N-acylation and N-α-ketoacylation of sulfoximines via the selective decarboxylation and dehydration of α-ketoacids. Chen Kang, Mingzhe Li, Wenxiu Huang, Shoucai Wang, Mengyu Peng, Longqiang Zhao, Guangbin Jiang, Fanghua Ji
, Green Chem.
, 2023
, 25
, 8838